Christopher M. Counter
George Barth Geller Distinguished Professor of PharmacologyOverview
The Counter lab studies the molecular mechanisms that underly to the onset of human cancers, with the goal to prevent cancer initiation or progression. The lab uses ultra-senstitive sequencing platforms and proteomic-coupled CRISPR/Cas9 screens to elucidate the factors that mold the mutational patterns selected to initiate the process of tumorigenesis. See https://counter.labs.duke.edu/ for further details.
Positions
George Barth Geller Distinguished Professor of Pharmacology in the School of Medicine
2021 School of Medicine
Professor of Pharmacology and Cancer Biology in the School of Medicine
2011 School of Medicine
Professor of Cell Biology in the School of Medicine
2022 School of Medicine
Assistant Professor in Radiation Oncology in the School of Medicine
2020 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2002 School of Medicine
Education
B.S., McMaster University (Canada) 1990
1990 McMaster University (Canada)
Ph.D., McMaster University (Canada) 1996
1996 McMaster University (Canada)
Postdoctoral Fellow, Massachusetts Institute of Technology, Whitehead Institute for Biomedical Research 1998
1998 Massachusetts Institute of Technology
Publications, Grants & Awards
- Grants (56)
- Awards (2)
- Academics Articles (101)
- Conference Pages (4)
National Institutes of Health
National Institutes of Health
National Institutes of Health
National Cancer Institute
American Society for Pharmacology and Experimental Therapeutics
Offices & Contact
C225 Lev Sci Res Ctr
Durham, NC
27708
Duke Box 3813
Durham, NC
27710